Tatva Chintan schedules investor meeting with Singularity AMC

Tatva Chintan Pharma Chem Limited has scheduled a physical, one-on-one meeting with investor Singularity AMC on November 20, 2025. This intimation, dated November 11, 2025, was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company confirmed that publicly available information would be referred to during the meeting, and no confidential or unpublished price sensitive information (UPSI) would be shared. The meeting schedule is subject to change.

Ishwar Nayi, company secretary and compliance officer, issued the announcement. The relevant information will also be made available on the company's website, www.tatvachintan.com.